Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00036
|
|||||
| Drug Name |
Cholesterol
|
|||||
| Synonyms |
(-)-Cholesterol; (3beta)-cholest-5-en-3-ol; 3-beta-Hydroxycholest-5-ene; 3beta-Hydroxycholest-5-ene; 5-Cholesten-3beta-ol; 5:6-Cholesten-3beta-ol; CCRIS 2834; Cholest-5-en-3-beta-ol; Cholest-5-en-3-ol (3beta)-; Cholest-5-en-3beta-ol; Cholesterin; Cholesterine; Cholesterol base H; Cholesteryl alcohol; Cholestrin; Cholestrol; Cordulan; Dastar; Dusoline; Dusoran; Dythol; HSDB 7; Hydrocerin; Kathro; Lanol; Lidinit; Lidinite; Nimco cholesterol base H; Provitamin D; Super hartolan; Tegolan; Tegolan (VAN); Wool alcohols B. P.
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Cone-Rod dystrophy [ICD11: 9B70] | Phase 2 | [1] | |||
| Structure |
|
![]() |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C27H46O
|
|||||
| Canonical SMILES |
CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C
|
|||||
| InChI |
InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1
|
|||||
| InChIKey |
HVYWMOMLDIMFJA-DPAQBDIFSA-N
|
|||||
| CAS Number |
CAS 17528-72-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 386.7 | Topological Polar Surface Area | 20.2 | ||
| Heavy Atom Count | 28 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 1 | |||
| XLogP |
8.7
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10318723
, 10586602
, 12159193
, 14927473
, 15054036
, 2231
, 24848759
, 24852491
, 24856217
, 24856220
, 24870712
, 24892329
, 24892335
, 24892388
, 24893064
, 24893094
, 24899653
, 25621399
, 26750557
, 26754461
, 29203946
, 29215267
, 29225011
, 3132495
, 3487
, 4266362
, 46393729
, 47211564
, 47722068
, 48421907
, 49684278
, 49688267
, 49786946
, 49833611
, 49854209
, 49903086
, 53787861
, 56311936
, 57323103
, 57647874
, 629186
, 74414
, 7847108
, 7886645
, 8025561
, 8145005
, 8153730
, 825929
, 827331
, 841782
|
|||||
| ChEBI ID |
ChEBI:15372
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | ABCA1 | Transporter Info | ATP-binding cassette sub-family A member 1 | Substrate | [2] | |
| ABCA12 | Transporter Info | ATP-binding cassette sub-family A member 12 | Substrate | [3] | ||
| ABCA2 | Transporter Info | ATP-binding cassette sub-family A member 2 | Substrate | [4] | ||
| ABCA5 | Transporter Info | ATP-binding cassette sub-family A member 5 | Substrate | [5] | ||
| ABCG1 | Transporter Info | ATP-binding cassette sub-family G member 1 | Substrate | [6] | ||
| BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [7] | ||
| NPC1L1 | Transporter Info | Niemann-Pick C1-like protein 1 | Substrate | [8] | ||
| P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [9] | ||
| References | ||||||
| 1 | ClinicalTrials.gov (NCT01773278) Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS) | |||||
| 2 | ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions. J Lipid Res. 2003 Jul;44(7):1373-80. | |||||
| 3 | ABCA12 regulates ABCA1-dependent cholesterol efflux from macrophages and the development of atherosclerosis. Cell Metab. 2013 Aug 6;18(2):225-38. | |||||
| 4 | The ATP-binding cassette transporter-2 (ABCA2) regulates cholesterol homeostasis and low-density lipoprotein receptor metabolism in N2a neuroblastoma cells. Biochim Biophys Acta. 2011 Dec;1811(12):1152-64. | |||||
| 5 | Mutations in the cholesterol transporter gene ABCA5 are associated with excessive hair overgrowth. PLoS Genet. 2014 May 15;10(5):e1004333. | |||||
| 6 | Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):139-43. | |||||
| 7 | Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis. J Biol Chem. 2003 Jun 6;278(23):20645-51. | |||||
| 8 | Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science. 2004 Feb 20;303(5661):1201-4. | |||||
| 9 | Cholesterol interaction with the daunorubicin binding site of P-glycoprotein. Biochem Biophys Res Commun. 2000 Oct 5;276(3):909-16. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
